Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound
- PMID: 31807329
- PMCID: PMC6856780
- DOI: 10.15557/JoU.2019.0034
Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound
Abstract
The diagnosis of gastrointestinal neuroendocrine neoplasms represents a significant diagnostic challenge since these tumours have a various, often non-specific clinical presentation. Currently, more than half of gastroenteropancreatic neuroendocrine neoplasms are detected incidentally, usually during surgery, diagnostic imaging studies or endoscopic procedures performed for other indications. Sometimes the first symptom of the disease is the presence of metastatic lesions in the liver. A neuroendocrine tumour is diagnosed based on the clinical presentation, assessment of specific and non-specific biochemical markers, imaging studies and histopathological examination. Focal lesions, both primary and metastatic may be small and often have an atypical location. Diagnostic imaging of neuroendocrine tumours is of fundamental importance for determining the location of the primary lesion, staging of the disease, selection of treatment and monitoring of its effects. In addition, diagnostic imaging make it possible not only to detect tumours, but also to perform therapeutic procedures based on the result. Transabdominal ultrasound is one of the first diagnostic imaging method for neuroendocrine neoplasms. New ultrasound techniques such as ultrasound elastography, contrast-enhanced ultrasound, endoscopic ultrasound, intraductal and intraoperative ultrasound improve the efficacy of ultrasound examination. Endoscopic ultrasound is a fundamental diagnostic tool for the detection of neuroendocrine tumours of the pancreas and the distal part of the colon. Due to the large variety of neuroendocrine tumours and differences in tumour biology, clinical stage and expression of somatostatin receptors, no single imaging method is sufficient; therefore, in order to determine the right diagnosis and select the best treatment, it is recommended that a combined morphological and functional assessment be used.
Keywords: diagnostic imaging; elastography; neuroendocrine tumours; ultrasound.
© Polish Ultrasound Society.
Conflict of interest statement
Conflict of interest The authors do not report any financial or personal affiliations to persons or organisations that could adversely affect the content of or claim to have rights to this publication.
References
-
- Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, Bałdys-Waligórska A, Bednarczuk T, Bolanowski M. et al.: Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 79–110. - PubMed
-
- Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM: The status of neuroendocrine tumor imaging: from darkness to light? Neuroendocrinology 2015; 101: 1–17. - PubMed
-
- Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA: Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013; 266: 38–61. - PubMed
-
- Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC: Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer 2008; 123: 867–873. - PubMed
Publication types
LinkOut - more resources
Full Text Sources